Therapeutic Dose Monitoring (TDM) of Tamoxifen
NCT05133674
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Breast Carcinoma
Breast Tumors
Cancer of Breast
Malignant Neoplasm of Breast
Interventions
DRUG:
Tamoxifen 20 mg
Sponsor
Karolinska University Hospital